Cartalax is associated in the research literature with the tripeptide Ala-Glu-Asp (AED). When its relevance to cartilage is discussed, however, an important distinction is often lost: most of the available evidence concerns molecular and cellular endpoints rather than structural changes to cartilage.
A 2023 study looked at AED in conjunction with a cartilage polypeptide complex in cell models associated with aging. The researchers measured the proteins and cytokines linked to the senescence-associated secretory phenotype, such as p16, p21, p53, TNF-α, IL-1α and Sirt1.
Other published work has examined AED in models of mesenchymal stem-cell aging, including changes in NF-κB, IGF1 and TNKS2 gene expression. A 2023 review placed those findings within the wider field of peptide-regulated chondrogenic differentiation.
These are specific experimental observations. They should not be interpreted as evidence that AED repairs cartilage, improves joint function, or produces a clinical outcome.
What Has Cartalax-Associated AED Actually Been Studied For?
| Research question | Experimental model or context | Endpoints examined |
|---|---|---|
| Does AED alter ageing-associated signalling in chondrocytes? | Ageing-associated chondrocyte model | p16, p21, p53, Sirt1, TNF-α, IL-1α |
| Does AED affect gene expression during MSC ageing? | Replicative and stationary MSC ageing models | NF-κB, IGF1 and TNKS2 |
| How does AED fit into cartilage differentiation research? | Review of peptide and MSC research | Chondrogenic differentiation pathways and molecular context |
The evidence therefore covers several related but distinct questions. Combining all of them under a broad claim about “cartilage health” would obscure what the experiments actually tested.
What Did the 2023 Chondrocyte Study Measure?
The 2023 study measured ageing-associated changes in p16, p21, p53, TNF-α, IL-1α and Sirt1 in chondrocytes and examined how AED affected this molecular profile.
The 2023 study by Myakisheva and colleagues provides one of the more direct experimental links between AED and cartilage-cell research.
Researchers compared AED with a cartilage polypeptide complex, or CPC, while examining the senescence-associated secretory phenotype (SASP) of chondrocytes.
The study identified an aging-associated pattern characterized by increased synthesis of:
- p16
- p21
- p53
- TNF-α
- IL-1α
By contrast, sirt1 synthesis was reduced.
The researchers reported that AED and CPC altered the synthesis of molecules making up this SASP profile.
This gives us a clearly defined experimental endpoint. The researchers examined molecular characteristics of aging-associated chondrocytes, rather than measuring cartilage thickness, biomechanical properties, or joint function.
That distinction substantially changes how we should interpret the study.
Why Were p16, p21 and p53 Measured?
The selection of p16, p21, and p53 provides useful context for understanding the experiment.
These proteins participate in cellular responses associated with cell-cycle control, stress, and senescence. Rather than measuring whether cartilage itself had changed, the researchers used these molecular markers to characterize the state of the cultured cells.
The researchers were looking for changes in aging-associated molecular markers within the chondrocytes. That distinction matters, since changes in cultured cells are not evidence that cartilage tissue has regenerated.
The first can be investigated through protein measurements in cultured cells. Demonstrating the second would require considerably more evidence.
Why Were TNF-α and IL-1α Included?
The same experiment also measured the cytokines TNF-α and IL-1α.
Their inclusion matters because SASP is not defined solely by changes in cell-cycle-associated proteins. Senescent cells can also display altered secretion of signaling molecules, including inflammatory-associated cytokines.
In the study, increased TNF-α and IL-1α synthesis formed part of the aging-associated chondrocyte profile, while AED exposure was associated with changes in this group of measured SASP molecules.
This provides a more precise interpretation than describing AED as broadly “anti-inflammatory.”
The experiment measured selected cytokines under particular laboratory conditions. It did not establish a general anti-inflammatory effect or demonstrate treatment of an inflammatory condition.
Where Does Sirt1 Fit Into the Experiment?
Sirt1 provides another part of the molecular picture.
Where p16, p21, p53, TNF-α and IL-1α were reported as increased in the aging-associated chondrocyte model, Sirt1 synthesis was decreased. AED and the cartilage polypeptide complex were subsequently reported to alter the synthesis profile of the SASP-associated molecules examined.
The experiment's value therefore lies in the patterns shown by multiple markers rather than in any one protein.
A simplified representation is:
The researchers then looked into whether AED changed that experimentally defined molecular profile.
This is considerably narrower than demonstrating a change to cartilage tissue itself.
What Has AED Research Found in Mesenchymal Stem-Cell Models?
AED research in MSC-ageing models has reported changes in NF-κB and IGF1 gene expression, and TNKS2 has also been examined in a replicative aging model.
A separate research strand concerns mesenchymal stem cells (MSCs).
This is important because MSCs and mature chondrocytes are not interchangeable experimental systems.
A 2023 review of peptide regulation of chondrogenic stem-cell differentiation discusses AED research involving replicative and stationary models of MSC aging.
The reported AED-associated endpoints included NF-κB, IGF1 and TNKS2 gene expression.
The review reported AED-associated differences in NF-κB and IGF1 gene expression in replicative and stationary MSC-ageing models, while TNKS2 expression was examined in the replicative model.
These observations add another layer to the AED literature, but they should not be merged with the chondrocyte findings.
One research question concerns molecular changes during MSC aging.
The other concerns the SASP profile of chondrocytes.
Keeping those models separate prevents a collection of cellular observations from becoming an unsupported claim about cartilage repair.
Does the MSC Evidence Show That AED Produces Chondrogenic Differentiation?
No, the AED findings discussed in the review concern specific gene-expression changes and do not establish that AED produces chondrogenic differentiation.
This is where the evidence requires particularly careful interpretation.
The 2023 review examines numerous peptides involved in chondrogenic differentiation and discusses pathways including WNT, ERK-p38 and Smad signaling. It also describes established chondrogenic markers such as SOX9, type II collagen and aggrecan.
However, those findings do not all belong to AED.
For AED specifically, the review highlights findings involving NF-κB, IGF1 and TNKS2 expression in MSC-ageing models. Other peptides discussed in the same review are associated with SOX9, aggrecan and type II collagen findings.
That distinction is important.
It would be inaccurate to take every chondrogenic endpoint described in the review and present it as an experimentally demonstrated effect of Cartalax-associated AED.
How Do the Chondrocyte and MSC Experiments Differ?
The chondrocyte study examined an aging-associated secretory phenotype, while the MSC research investigated gene-expression changes in cellular aging models.
The two research areas address different biological questions.
The chondrocyte study looked at an aging-associated secretory phenotype. Its reported endpoints included p16, p21, p53, TNF-α, IL-1α and Sirt1.
The MSC research examined gene-expression changes in models of replicative and stationary aging, including NF-κB and IGF1, and also examined TNKS2 in a replicative model.
That means the literature cannot be reduced to a single mechanism such as: AED -> cartilage formation
Instead, the published research contains several separate observations from different experimental systems.
That is scientifically more interesting, but it also requires more cautious interpretation.
What Can Molecular Markers Tell Researchers About Cartilage Biology?
Molecular markers help researchers determine whether a particular cellular process changes under controlled experimental conditions.
They are often an early step in mechanistic research.
But a considerable evidence gap remains between altered molecular signaling and changes in cartilage tissue.
A simplified hierarchy would look like this:
Most of the evidence on Cartalax, discussed here, lies in the molecular and cellular parts of that sequence.
For example, the 2023 paper reports SASP-associated molecular measurements; the indexed abstract includes no mechanical testing or structural cartilage endpoints.
That is why the researchers cannot base their conclusion that AED affects the structure or mechanical properties of cartilage on those results alone.
Where Does the Current Cartalax Evidence Stop?
Current Cartalax research provides molecular and cellular findings, but does not establish cartilage regeneration, structural repair, improved joint function, or human clinical outcomes.
This is perhaps the most important question when reviewing the literature.
The available research provides evidence that AED has been investigated against defined molecular endpoints in cell-based experimental systems.
It does not, on the basis of the studies discussed here, establish:
- cartilage regeneration
- structural cartilage repair
- improved cartilage mechanical properties
- changes in tissue-level function
- clinical outcomes
This remains true even where the original researchers discuss possible disease relevance or therapeutic implications.
Those interpretations should be separated from the measurements actually made.
The latter is the experimentally supported observation.
What Would Strengthen the Cartalax Cartilage Evidence?
Several gaps remain.
Independent replication is important. Repeating AED experiments in laboratories separate from the originating research program would help establish how reproducible the reported findings are.
Additional chondrocyte models would also be useful. Findings from one cellular system cannot automatically be assumed to occur under different culture conditions or biological contexts.
Experiments examining multiple defined laboratory concentrations could help determine whether the reported molecular changes vary systematically with AED concentration.
Measuring the extracellular matrix would strengthen the evidence beyond intracellular and signaling-related markers. After that, the researchers could examine whether the molecular changes correspond to observable changes in the production or organization of cartilage-associated matrix.
Three-dimensional and tissue-level models would add biological complexity that conventional cell culture cannot reproduce.
Finally, studies measuring structural or biomechanical endpoints would be needed before moving from observations about molecular markers to conclusions about cartilage tissue.
These are not minor details. They represent different levels of experimental evidence.
What Does the Cartalax Evidence Currently Show?
Current research supports a relatively narrow conclusion.
The Cartalax-associated tripeptide AED has been investigated in cartilage-relevant experimental systems.
A 2023 chondrocyte study examined p16, p21, p53, TNF-α, IL-1α, and Sirt1 within an aging-associated secretory phenotype and reported changes following AED exposure.
Separate MSC research has examined AED-associated changes in NF-κB, IGF1, and TNKS2 gene expression under specific cellular aging conditions.
These findings provide hypotheses for further investigation.
They do not demonstrate cartilage repair, regeneration, or a clinical outcome.
Frequently Asked Questions About Cartalax Cartilage Research
Published AED research has examined molecular endpoints in cartilage-relevant cellular models, including aging-associated signaling in chondrocytes and gene expression in MSC-ageing models.
Researchers measured p16, p21, p53, TNF-α, IL-1α, and Sirt1 as part of the senescence-associated secretory phenotype of chondrocytes.
Yes, a 2023 review examined NF-κB, IGF1, and TNKS2 gene expression in replicative and stationary MSC-ageing models.
No, the cellular and molecular findings discussed here do not demonstrate cartilage regeneration or structural repair.
No. AED is Ala-Glu-Asp, whereas AEDG contains an additional glycine residue. Findings involving AEDG should therefore not automatically be attributed to AED.
Carrying out independent replications, using additional cellular models, conducting dose-response experiments, and carrying out studies that measure extracellular matrix, tissue-level, and biomechanical endpoints would help establish whether the molecular observations reported extend beyond the existing experimental systems.
Scientific references
- 1 Myakisheva SN, Linkova NS, Kozhevnikova EO, Polyakova VO, Ryzhak GA. [Peptides prevent the forming of secretory phenotype of chondrocytes associated with the aging.]. Adv Gerontol. 2023;36(2):234-238. Russian. https://pubmed.ncbi.nlm.nih.gov/37356100/
- 2 Linkova N, Khavinson V, Diatlova A, Myakisheva S, Ryzhak G. Peptide Regulation of Chondrogenic Stem Cell Differentiation. Int J Mol Sci. 2023 May 8;24(9):8415. doi: 10.3390/ijms24098415. https://pubmed.ncbi.nlm.nih.gov/37176122/
Research-use disclaimer: For research and laboratory use only. Not for human or animal consumption.
